Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
October 9, 2019
IDEAYA Announces First Patient Dosing of IDE196 for Solid Tumors Outside of Uveal Melanoma and a Collaboration with Foundation Medicine in Support of its Tumor-Agnostic GNAQ/11 Basket Trial
October 7, 2019
Aprea Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 7, 2019
Audentes Therapeutics Presents New Positive Data From ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked Myotubular Myopathy (XLMTM), at the 24th International Annual Congress of the World Muscle Society
October 7, 2019
Cabaletta Bio Announces Presentation of Preclinical Data Showing Specific CAAR T Activity Against Anti-MuSK Expressing B Cells
October 3, 2019
Aprea Therapeutics Announces Pricing of Initial Public Offering
October 3, 2019
NIH SBIR Grant Awarded to Accelerate Magnetic Particle Imaging in Cancer Immunology
October 3, 2019
Arvinas Strengthens Scientific Advisory Board With Leaders in Oncology and Neurological Disorders
October 3, 2019
Vor Biopharma Hires Senior Cell and Gene Therapy Leaders as Chief Technology Officer and Vice President of Research
October 3, 2019
Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio
October 1, 2019
Cabaletta Bio Receives IND Clearance from FDA to Initiate First Clinical Trial of DSG3-CAART in Patients with Mucosal Pemphigus Vulgaris
« Previous Page
1
2
3
4
5
6
…
12
Next Page »